Td Private Client Wealth LLC Ocugen, Inc. Transaction History

Td Private Client Wealth LLC

  • $3.48 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Aug 16, 2024
BUY
$6.36 - $8.51 $625,760 - $837,298
98,390 New
98,390 $706 Million
Q2 2021

Aug 16, 2024
SELL
$5.52 - $15.68 $55,199 - $156,800
-10,000 Reduced 9.23%
98,390 $790 Million
Q1 2021

Aug 16, 2024
BUY
$1.66 - $15.81 $179,927 - $1.71 Million
108,390 New
108,390 $736 Million

Others Institutions Holding OCGN

# of Institutions
124
Shares Held
78.3M
Call Options Held
535K
Put Options Held
523K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $195M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email